ReviewMolecular cancer2024

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.

Chang-Yun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.